Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nan-ping Weng

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Vaccines|December 23, 2023
A Phase I/II Clinical Trial of Intradermal, Controllable Self-Replicating Ribonucleic Acid Vaccine EXG-5003 against SARS-CoV-2Takenao Koseki, Mayumi Teramachi, Minako Koga, et al.
Elife|August 17, 2023
Epigenetic signature of human immune aging in the GESTALT studyRoshni Roy, Pei-Lun Kuo, Julián Candia, et al.
Immunity|June 15, 2022
DNA methylation signatures reveal that distinct combinations of transcription factors specify human immune cell epigenetic identityRoshni Roy, Senthilkumar Ramamoorthy, Benjamin D Shapiro, et al.
Immunity|October 27, 2021
DNA methylation signatures reveal that distinct combinations of transcription factors specify human immune cell epigenetic identityRoshni Roy, Senthilkumar Ramamoorthy, Benjamin D Shapiro, et al.
Nature Communications|October 23, 2023
SARS-CoV-2 infection establishes a stable and age-independent CD8<sup>+</sup> T cell response against a dominant nucleocapsid epitope using restricted T cell receptorsCecily Choy, Joseph Chen, Jiangyuan Li, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Vaccines|December 23, 2023
A Phase I/II Clinical Trial of Intradermal, Controllable Self-Replicating Ribonucleic Acid Vaccine EXG-5003 against SARS-CoV-2Takenao Koseki, Mayumi Teramachi, Minako Koga, et al.
Elife|August 17, 2023
Epigenetic signature of human immune aging in the GESTALT studyRoshni Roy, Pei-Lun Kuo, Julián Candia, et al.
Immunity|June 15, 2022
DNA methylation signatures reveal that distinct combinations of transcription factors specify human immune cell epigenetic identityRoshni Roy, Senthilkumar Ramamoorthy, Benjamin D Shapiro, et al.
Immunity|October 27, 2021
DNA methylation signatures reveal that distinct combinations of transcription factors specify human immune cell epigenetic identityRoshni Roy, Senthilkumar Ramamoorthy, Benjamin D Shapiro, et al.
Nature Communications|October 23, 2023
SARS-CoV-2 infection establishes a stable and age-independent CD8<sup>+</sup> T cell response against a dominant nucleocapsid epitope using restricted T cell receptorsCecily Choy, Joseph Chen, Jiangyuan Li, et al.
Pageof 9